Latest Articles

Publication Date
All News Scientific
‘No stage 5’: Tauranga mum’s cancer fight - SunLive

‘No stage 5’: Tauranga mum’s cancer fight SunLive

Published: March 2, 2025, 4 p.m.
Read Full Article
‘No stage 5’: Tauranga mum’s cancer fight - web2.sunlive.co.nz

‘No stage 5’: Tauranga mum’s cancer fight web2.sunlive.co.nz

Published: March 2, 2025, 4 p.m.
Read Full Article
ITV star issues desperate plea to fans after cancer heartbreak - Birmingham Live

ITV star issues desperate plea to fans after cancer heartbreak Birmingham Live

Published: March 1, 2025, 11:57 a.m.
Read Full Article
Tumor Volume Index as a Predictor of Pelvic Lymph Node Metastasis in Low-Risk Endometrial Cancer - Cureus

Tumor Volume Index as a Predictor of Pelvic Lymph Node Metastasis in Low-Risk Endometrial Cancer Cureus

Published: Feb. 28, 2025, 6:36 p.m.
Read Full Article
"I went for a hysterectomy for endometriosis and woke up to discover I had ovarian cancer at 33." - SussexWorld

"I went for a hysterectomy for endometriosis and woke up to discover I had ovarian cancer at 33." SussexWorld

Published: Feb. 28, 2025, 4:07 p.m.
Read Full Article
Researchers in Oregon are slowing down cancer by remotely cooking tumors - Oregon Public Broadcasting

Researchers in Oregon are slowing down cancer by remotely cooking tumors Oregon Public Broadcasting

Published: Feb. 28, 2025, 2 p.m.
Read Full Article
Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis - BioMed Central

Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis BioMed Central

Published: Feb. 28, 2025, 10:47 a.m.
Read Full Article
Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis - bmcwomenshealth.biomedcentral.com

Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis bmcwomenshealth.biomedcentral.com

Published: Feb. 28, 2025, 10:47 a.m.
Read Full Article
‘Experts shortage major cause of cancer deaths’ - Punch Newspapers

‘Experts shortage major cause of cancer deaths’ Punch Newspapers

Published: Feb. 28, 2025, 2:12 a.m.
Read Full Article
Patterns of associations with epidemiologic factors by high grade serous ovarian cancer gene expression subtypes.

Ovarian high-grade serous carcinomas (HGSC) comprise four distinct molecular subtypes based on mRNA expression patterns, with differential survival. Understanding risk factor associations is important to elucidate the etiology of HGSC. …

Published: Feb. 26, 2025, midnight
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!